-
1
-
-
0023578342
-
Transmucosal passage of poly-alkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine
-
Aprahamian M, et al. Transmucosal passage of poly-alkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine. Biol Cell 1987;61:69-76.
-
(1987)
Biol Cell
, vol.61
, pp. 69-76
-
-
Aprahamian, M.1
-
2
-
-
0035966497
-
Biodegradable polymeric nanoparticles as drug delivery devices
-
Soppimath KS, et al. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001;70:1-20.
-
J Control Release
, vol.2001
, pp. 701-720
-
-
Soppimath, K.S.1
-
3
-
-
0030993565
-
The oral absorption of micro- and nanoparticulates: Neither exceptional nor unusual
-
Florence AT. The oral absorption of micro- and nanoparticulates: neither exceptional nor unsual Pharm Res 1997;14(3):259-66
-
(1997)
Pharm Res
, vol.14
, Issue.3
, pp. 259-266
-
-
Florence, A.T.1
-
4
-
-
0035478442
-
Transcytosis of nanoparticle and dendrimer delivery systems: Evolving vistas
-
Florence AT, Hussain N. Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas. Adv Drug Deliv Rev 2001;50:S69-89.
-
(2001)
Adv Drug Deliv Rev
, vol.50
-
-
Florence, A.T.1
Hussain, N.2
-
5
-
-
0034658557
-
Ex vivo and in situ PLGA microspheres uptake by pig ileal Peyer's patch segment
-
Torche A-M, et al. Ex vivo and in situ PLGA micropheres uptake by pig ileal Peyer's patch segment. Int J Pharm 2000;201:15-27.
-
(2000)
Int J Pharm
, vol.201
, pp. 15-27
-
-
Torche, A.-M.1
-
6
-
-
0345647081
-
Polymeric nanoparticles as delivery system for influenza virus glycoproteins
-
Lencome D, Preat V. Polymeric nanoparticles as delivery system for influenza virus glycoproteins. J Control Release 1998;54:15-27.
-
(1998)
J Control Release
, vol.54
, pp. 15-27
-
-
Lemoine, D.1
Preat, V.2
-
7
-
-
0031395214
-
Development and characterization protein-loaded poly(lactide-glycolide) nanospheres
-
Blanco MD, Alonso MJ. Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres. Eur J Pharm Biopharm 1997;43: 287-94.
-
(1997)
Eur J Pharm Biopharm
, vol.43
, pp. 287-294
-
-
Blanco, M.D.1
Alonso, M.J.2
-
8
-
-
0032210766
-
Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)-poly(lactide/glycolide) nanopheres
-
Sun H et al. Regulation of smooth muscle cell proliferation using paclitaxel loaded poly(ethylene oxide)-poly(lactide/glycolide) nanopheres. J Biomed Mater Res 1998;42:331-8.
-
(1998)
J Biomed Mater Res
, vol.42
, pp. 331-338
-
-
Suh, H.1
-
9
-
-
0031060457
-
Formulation and characterizaion of biodegradable nanoparticles for intravascular local drug delivery
-
Song CX, et al. Formulation and characerizaion of biodegradable nanoparticles for intravascular local drug delivery. J Control Release 1997;43:197-212
-
(1997)
J Control Release
, vol.43
, pp. 197-212
-
-
Song, C.X.1
-
10
-
-
0031751935
-
A poly(D,L-lactide-co-glycolide) microsphere depot system for delivery of haloperidol
-
Cheng Y-H, Illum L, Davis SS. A poly(D,L-lactide-co-glycolide) microsphere depot system for delivery of haloperidol. J Control Release 1998;55:203-12.
-
(1998)
J Control Release
, vol.55
, pp. 203-212
-
-
Cheng, Y.-H.1
Illum, L.2
Davis, S.S.3
-
11
-
-
0035848417
-
Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers
-
Feng S-S, Huang G. Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. J Control Release 2001;71:53-69
-
(2001)
J Control Release
, vol.71
, pp. 53-69
-
-
Feng, S.-S.1
Huang, G.2
-
12
-
-
0037122736
-
Design of biodegradable particles for protein delivery
-
Vila A, et al. Design of biodegradable particles for protein delivery. J Control Release 2002;78:15-24
-
(2002)
J Control Release
, vol.78
, pp. 15-24
-
-
Vila, A.1
-
13
-
-
0031060393
-
Protein-loaded poly(DL-lactide-co-glycolide) microparticles for oral administration: Formulation, structural and release characteristics
-
Rafati H, et al. Protein loaded Poly (DL-lactide-co-glycolide) microparticles for oral administration: formulation, stuctural and release characteristics. J Control Release 1997;43:89-102.
-
(1997)
J Control Release
, vol.43
, pp. 89-102
-
-
Rafati, H.1
-
14
-
-
0035795022
-
PEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in rats
-
Li Y-P, et al. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodisribution in rats. J Control Release 2001;71:203-11.
-
(2001)
J Control Release
, vol.71
, pp. 203-211
-
-
Li, Y.-P.1
-
16
-
-
0035973480
-
Preparation of PLGA nanoparticles containing estrogen by emulsification- diffusion method
-
Kwon H-Y, et al. Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method. Colloids Surf 2001;182:123-30.
-
(2001)
Colloids Surf
, vol.182
, pp. 123-130
-
-
Kwon, H.-Y.1
-
17
-
-
0035937594
-
Mucoadhesive nanoparticulate systems for peptide drug delivery
-
Takeuchi H, Yamamoto H, Kawashima Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv Drug Delivery 2001;47:39-54.
-
(2001)
Adv Drug Deliv
, vol.47
, pp. 39-54
-
-
Takeuchi, H.1
Yamamoto, H.2
Kawashima, Y.3
-
18
-
-
0032952283
-
PLGA nanoparticles prepared by nanoprecipitation: Drug loading and release studies of a water soluble drug
-
Govender T, et al. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release 1999;57:171-85.
-
(1999)
J Control Release
, vol.57
, pp. 171-185
-
-
Govender, T.1
-
19
-
-
0032851413
-
Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method
-
Murakami H, et al. Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int J Pharm 1999;187:143-52.
-
(1999)
Int J Pharm
, vol.18
, pp. 143-152
-
-
Murakami, H.1
-
20
-
-
0141607610
-
Preparation and characterization of nanoparticles containing an antihypertensive agent
-
Verger ML-L, et al. Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur J Pharm Biopharm 1998;46:137-43.
-
(1998)
Eur J Pharm Biopharm
, vol.46
, pp. 137-143
-
-
Verger, M.-L.1
-
21
-
-
0343026322
-
Biodegradable nanoparticles-from sustained release formulations to improved site specific drug delivery
-
Leroux J-C, et al. Biodegradable nanoparticles-from sustained release formulations to improved site specific drug delivery. J Control Release 1996;39:339-50.
-
(1996)
J Control Release
, vol.39
, pp. 339-350
-
-
Leroux, J.-C.1
-
22
-
-
0035937591
-
Design of nanoparticles composed of graft copolymers for oral peptide delivery
-
Sakuma S, Hayashi M, Akashic M. Design of nanoparticles composed of graft copolymers for oral peptide delivery. Adv Drug Delivery 2001;47:21-37.
-
(2001)
Adv Drug Deliv
, vol.47
, pp. 21-37
-
-
Sakuma, S.1
Hayashi, M.2
Akashi, M.3
-
23
-
-
0035371978
-
Poly n-butyl cyanoacrylate nanoparticles: A mechanistic study of polymerisation and particle formation
-
Behan N, Birkenshaw C, Clarke N. Poly n-butyl cyanoacrylate nanoparticles: a mechanistic study of polymerisation and particle formation. Biormaterials 2001;22:1335-44.
-
(2001)
Biomaterials
, vol.22
, pp. 1335-1344
-
-
Behan, N.1
Birkinshaw, C.2
Clarke, N.3
-
24
-
-
0035937593
-
Polysaccharide colloidal particles as delivery systems for macromolecules
-
Janes KA, Calvo P, Alonso MJ. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv 2001;47:83-97.
-
(2001)
Adv Drug Deliv
, vol.47
, pp. 83-97
-
-
Janes, K.A.1
Calvo, P.2
Alonso, M.J.3
-
25
-
-
0013393014
-
Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles
-
in press
-
Hu Y. et al. Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles. Biomaterials, in press.
-
Biomaterials
-
-
Hu, Y.1
-
26
-
-
0032104413
-
Preparation, characterizaion and in vitro anti-microbial activity of ampicillin-loaded polyethylcyanoacrylate nanoparticles
-
Fontana G, et al. Preparation, charaterization and in vitro anti-microbial activity of ampicillin-loaded polyethylcyanoacrylate nanoparticles. Biomaterials 1998;19:1009-17.
-
(1998)
Biomaterials
, vol.19
, pp. 1009-1017
-
-
Fontana, G.1
-
27
-
-
0032949487
-
Stability and freeze-drying drying of cyclosporine loaded poly(D,L-lactide-glycolide) carriers
-
Chacon M, et al. Stability and freeze-drying of cyclosporine loaded poly (D,L-lactide-glycolide) carriers. Eur J Pharm Sci 1999;8:99-107.
-
(1999)
Eur J Pharm Sci
, vol.8
, pp. 99-107
-
-
Chacon, M.1
-
28
-
-
0033790335
-
Freeze-drying of polycarolactone and poly(D,L-lactic-glycolic) nanoparticles induces minor particle size changes affecting the oral pharmacokinetics of loaded drugs
-
Saez A, et al. Freeze-drying of polycarolactone and poly(D,L-lactic-glycolic) nanoparticles induces minor particle size changes affecting the oral pharmacokinetics of loaded drugs. Eur J Pharm Biopharm 2000;50:379-87.
-
(2000)
Eur J Pharm Biopharm
, vol.50
, pp. 379-387
-
-
Saez, A.1
-
29
-
-
0035937595
-
Nonoparticulate systems for brain delivery of drugs
-
Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv 2001;47:65-81.
-
(2001)
Adv Drug Deliv
, vol.47
, pp. 65-81
-
-
Kreuter, J.1
-
30
-
-
0035856766
-
Synthesis and characterization of poly(ethyl-2-cyanoacrylate) nanoparticles
-
Arias JL, et al. Synthesis and characterization of poly(ethyl-2-cyanoacrylate) nanoparticles. J Control Release 2001;77: 309-21.
-
(2001)
J Control Release
, vol.77
, pp. 309-321
-
-
Arias, J.L.1
-
31
-
-
0034907767
-
Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: Influence of PEG coating on the particle size, drug release rate and phagocytic uptake
-
Fontana G, et al. Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: influence of PEG coating on the particle size, drug release rate and phagocytic uptake. Biomaterials 2001;22:2857-65.
-
(2001)
Biomaterials
, vol.22
, pp. 2857-2865
-
-
Fontana, G.1
-
32
-
-
0034601237
-
Sulfolbutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide)s facilitate the preparation of small negatively charged biodegradable nanospheres
-
Jung T, Breitenbach A, Kissel T, Sulfolbutylated poly(vinyl alcohol)- graft-poly(lactide-co-glycolide)s facilitate the preparation of small negatively charged biodegradable nanospheres. J Control Release 2000;67: 157-69.
-
(2000)
J Control Release
, vol.67
, pp. 157-169
-
-
Jung, T.1
Breitenbach, A.2
Kissel, T.3
-
33
-
-
0000972145
-
In vitro and in vivo anti-tumor activities of nonoparticles based on doxorubicin-PLGA conjugates
-
Yoo HS, et al. In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates. J Control Release 2000;68:419-31.
-
(2000)
J Control Release
, vol.68
, pp. 419-431
-
-
Yoo, H.S.1
-
34
-
-
0035910887
-
Design of triptorelin loaded nanopheres for transdermal iontophoretic administration
-
Nicoli S, et al. Design of triptorelin loaded nanospheres for transdermal iontophoretic administration. Int J Pharm 2001;214:31-5.
-
(2001)
Int J Pharm
, vol.214
, pp. 31-35
-
-
Nicoli, S.1
-
35
-
-
0035937599
-
Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future
-
Muller RE, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv 2001;47:3-19.
-
(2001)
Adv Drug Deliv
, vol.47
, pp. 3-19
-
-
Muller, R.H.1
Jacobs, C.2
Kayser, O.3
-
36
-
-
0343191443
-
'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption
-
Gref R, et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption Colloids Surf B 2000;18:301-13.
-
(2000)
Colloids Surf B
, vol.18
, pp. 301-313
-
-
Gref, R.1
-
37
-
-
0343962248
-
The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration
-
Ferro M, et al. The role of PEG on the stability in digestive fluids and in vivo hate of PER PLA nanoparticles following oral administration. Colloids Surf B 2000;18:315-23.
-
(2000)
Colloids Surf B
, vol.18
, pp. 315-323
-
-
Tobio, M.1
-
38
-
-
0032588348
-
Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting
-
Perat MIT, et al. Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. J Control Release 1999;60:121-8.
-
(1999)
J Control Release
, vol.60
, pp. 121-128
-
-
Panagi, Z.1
-
39
-
-
0035912958
-
Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles
-
Panagi Z, et al. Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles. Intl J Pharm 2001; 221:143-52
-
(2001)
Intl J Pharm
, vol.22
, pp. 1143-1152
-
-
Panagi, Z.1
-
40
-
-
0035936975
-
Drug delivery poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: In vitro characterization and in vivo evaluation
-
Redhead HM, Davis SS, Illum L. Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908 in vitro characterization and in vivo evaluation. J Control Release 2001;70:353-63.
-
(2001)
J Control Release
, vol.70
, pp. 353-363
-
-
Redhead, H.M.1
Davis, S.S.2
Illum, L.3
-
41
-
-
0033997473
-
Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis
-
Fishbein I, et al. Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis. J Control Release 2000;65: 221-9.
-
(2000)
J Control Release
, vol.65
, pp. 221-229
-
-
Fishbein, I.1
-
42
-
-
0031826949
-
Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: Results with an acute dog model
-
Song C, et al. Afterial uptake of biodegradable nanoparticles for intravascular local drug delivery: Results with an acute dog model. J Control Release 1998;54:201-11.
-
(1998)
J Control Release
, vol.54
, pp. 201-211
-
-
Song, C.1
-
43
-
-
0035937598
-
Lymphatic targeting with nanoparticulate system
-
Nishioka Y, Yoshino H. Lymphatic targeting with nanoparticulate system. Adv Drug Deliv 2001;47:55-64.
-
(2001)
Adv Drug Deliv
, vol.47
, pp. 55-64
-
-
Nishioka, Y.1
Yoshino, H.2
-
44
-
-
0035937597
-
Nanoparticulate systems for the delivery of antisense oligonucleotides
-
Lambert G, Fattal E, Couvreur P. Nanoparticulate systems for the delivery of antisense oligonucleotides. Adv Drug Deliv 2001;47:99-112
-
(2001)
Adv Drug Deliv
, vol.47
, pp. 99-112
-
-
Lambert, G.1
Fattal, E.2
Couvreur, P.3
-
45
-
-
0035838366
-
Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA
-
Perez C, et al. Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. J Control Release 2001;75:211-24.
-
(2001)
J Control Release
, vol.75
, pp. 211-224
-
-
Perez, C.1
-
46
-
-
0035940314
-
Chitosan as a novel nasal delivery system for vaccines
-
Illum L, et al. Chitosan as a novel nasal delivery system for vaccines. Adv Drug Deliv Rev 2001;51:81-96.
-
(2001)
Adv Drug Deliv Rev
, vol.51
, pp. 81-96
-
-
Illum, L.1
-
47
-
-
0035859983
-
Chitosan nanoparticles: A new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A
-
DeCampos A, Sanchez A, Alonso M. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface Application to cyclosporin A. Int J Pharm 2001;224:159-68.
-
(2001)
Int J Pharm
, vol.224
, pp. 159-168
-
-
DeCampos, A.1
Sanchez, A.2
Alonso, M.3
-
48
-
-
0032815462
-
Preparation of nanoparticles consisted of poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) and their evolution in vitro
-
Matsumoto J, et al. Preparation of nanoparticles consisted of poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) and their evolution in vitro. Int J Pharm 1999;185:93-101.
-
(1999)
Int J Pharm
, vol.185
, pp. 93-101
-
-
Matsumoto, J.1
-
49
-
-
0037133087
-
PLGA-mPEG nanoparticles of cisplatin: In vitro nanoparticle degradation, in vivo drug release and in vivo drug residence in blood properties
-
Avgoustakis K, et al. PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vivo drug release and in vivo drug residence in blood properties. J Control Release 2002;79:123-35.
-
(2002)
J Control Release
, vol.79
, pp. 123-135
-
-
Avgoustakis, K.1
|